International Colloquium on Infectious diseases and Antibiotics, 2017

Topics

• Bioterrorism & Preparedness
• Antimicrobial Resistance
• Molecular Diagnostics & Epidemiology
• Food borne & Water borne Illnesses
• Vector borne Diseases
• Nosocomial Infections
• Reemergence of vaccine preventable diseases
• Zoonotic Diseases
• Intersection of chronic diseases and infectious diseases
• Global trade and emerging infectious diseases
• Novel issues in HIV/AIDS control
• Global health security agenda
• Increasing understanding of the microbiome & Malaria
• Challenges in prevention of healthcare-associated infections
• Influenza & Polio
• Emerging Infections Program (EIP)
• Integration of public health and primary care & infectious disease clinicians
• Use of bioinformatics and big data in public health
• Emergence and pathogenesis of coronaviruses
• Infections from contaminated pharmaceuticals or counterfeit medications
• Emerging Infectious diseases
• Ebola viruses
• Pathogen discovery and investigation of new syndromes
• Healthcare associated infections
• Social determinants of emerging infectious diseases
• Sexually transmitted diseases
• Immuno-epidemiology
• Global issues concerning vaccine preventable diseases
• Antibiotic Resistance: Opportunities and Challenges
• Ecology of infectious diseases
• Antibiotics and Allergies: Clinical Update
• Inflammatory and Infectious Diseases
• Clinical Biochemistry & Clinical Microbiology
• Antibiotic Prophylaxis
• Antibiotics & Business Opportunities
• Emerging trends, Barriers and Opportunities
• Clinical Trials of Antibiotics
• Antibiotics for Emerging and Re-emerging Diseases
• Antibiotics Mechanism &Safety
• Antibiotic and antiviral drug resistance
• Antibiotics for Trauma and Surgical Infections
• Antibiotics in Anti-Aging
• Drug Discovery & Novel Delivery Technologies
• Challenges in Malaria Research
• Preservation of Antibiotics

Who should Attend

• Chief Medical Officers of Health
• Medical Officers of Health
• Provincial Epidemiologists
• Public Health Nurses
• Public Health Inspectors
• Communicable Disease Control Unit Directors
• Public Health Policy Advisors
• Public Health Program Managers
• Public Health Agency
• Antibiotics Service Organizations
• Researchers
• Students
• Physicians
• Directors
• Specialists
• Oncology scientists
• Health care professionals
• Researchers
• Lecturers and Students from Academia in the study of Antibiotics studies.
• Professors